Found 12 matching trials
CART-meso in Mesothelin Expressing Cancers
PHASE1Phase I study to establish safety and feasibility of intravenously administ...
Location
Abramson Cancer Center of the University of Pennsylvania
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
PHASE1RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer
PHASE1The goal of this clinical trial is to study the feasibility and efficacy of...
Location
The Second Affiliated hospital of Zhejiang University School of Medicine
The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer
EARLY_PHASE1The goal of this clinical trial is to study the safety and feasibility of a...
Location
Shanghai 6th People's Hospital
CAR T Cells in Mesothelin-Expressing Breast Cancer
PHASE1Phase 1 - Safety and Proof of Concept...
Location
University of Pennsylvania
MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
EARLY_PHASE1The goal of this clinical trial is to study the feasibility and efficacy of...
Location
The Second Affiliated hospital of Zhejiang University School of Medicine
CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor
PHASE1This is a single-arm, open-label, one center clinical study, to determine t...
Location
Ningbo No.5 Hospital (Ningbo Cancer Hospital)
A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma
PHASE1Pancreatic carcinoma typically has a high recurrence rate and very poor pro...
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Autologous Redirected RNA Meso-CIR T Cells
PHASE1To determine the safety and manufacturing feasibility of IV autologous chim...
Location
Abramson Cancer Center of the University of Pennsylvania
Anti-mesothelin CAR-T Cells With Advanced Refractory Solid Tumors
PHASE1The goal of this clinical trial is to study the safety, efficacy, and pharm...
Location
Department of Oncology, Ruijin Hospital